Soo-Jin Kim

Directeur Technique/Scientifique/R&D chez INOZYME PHARMA, INC.

Fortune : 2 M $ au 31/05/2024

Health Technology

Consumer Services

Postes actifs de Soo-Jin Kim

Sociétés	Poste	Début	Fin
INOZYME PHARMA, INC.	Directeur Technique/Scientifique/R&D	08/03/2022	-

Sociétés	Poste	Début	Fin
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Corporate Officer/Principal	-	-
HANMI PHARM. CO., LTD.	Corporate Officer/Principal	-	-
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	-	-

Cornell University	Undergraduate Degree
California Institute of Technology	Doctorate Degree

Internationale

Etats-Unis	6
Corée du Sud	2

Opérationnelle

Corporate Officer/Principal	3
Undergraduate Degree	1
Doctorate Degree	1

Sectorielle

Health Technology	5
Consumer Services	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	3
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
HANMI PHARM. CO., LTD.	Health Technology
INOZYME PHARMA, INC.	Health Technology

Entreprise privées	1
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Health Technology

Entreprise privées

Health Technology